Following treatment with TGF-β, control lung pulmospheres showed increased ZOI% while treatment of IPF pulmospheres with nintedanib or pirfenidone lowered the invasion area, suggesting that the degree of fibrosis can be modulated using known treatments. The gene discussed is TGFB1; the disease is idiopathic pulmonary fibrosis.